Charles Schwab Investment Management Inc Aldeyra Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 137,985 shares of ALDX stock, worth $296,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

137,985

Previous 136,733 0.92%

Holding current value

$296,667

Previous $682,000 16.28%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$4.7 - $6.98 $5,884 - $8,738	1,252 Added 0.92%	137,985 $793,000
Q2 2024 Aug 12, 2024	BUY	$3.25 - $4.72 $36,426 - $52,901	11,208 Added 8.93%	136,733 $452,000
Q2 2023 Aug 09, 2023	BUY	$7.11 - $11.89 $734,633 - $1.23 Million	103,324 Added 465.4%	125,525 $1.05 Million
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $269,018 - $536,928	-110,707 Reduced 83.3%	22,201 $89,000
Q1 2022 May 13, 2022	BUY	$3.25 - $5.17 $14,699 - $23,383	4,523 Added 3.52%	132,908 $591,000
Q4 2021 Feb 11, 2022	BUY	$3.5 - $9.63 $12,946 - $35,621	3,699 Added 2.97%	128,385 $514,000
Q3 2021 Nov 16, 2021	SELL	$7.94 - $11.31 $3,279 - $4,671	-413 Reduced 0.33%	124,686 $1.1 Million
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $1.12 Million - $1.59 Million	106,972 Added 590.13%	125,099 $1.42 Million
Q3 2020 Nov 13, 2020	BUY	$4.0 - $7.53 $72,508 - $136,496	18,127 New	18,127 $135,000
Q2 2020 Aug 14, 2020	SELL	$1.97 - $5.05 $103,785 - $266,049	-52,683 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.62 - $6.4 $8,041 - $31,769	-4,964 Reduced 8.61%	52,683 $131,000
Q4 2019 Feb 07, 2020	BUY	$4.73 - $7.98 $19,445 - $32,805	4,111 Added 7.68%	57,647 $335,000
Q3 2019 Nov 08, 2019	SELL	$4.41 - $6.12 $35,280 - $48,960	-8,000 Reduced 13.0%	53,536 $283,000
Q2 2019 Aug 09, 2019	BUY	$6.0 - $9.0 $118,956 - $178,434	19,826 Added 47.53%	61,536 $370,000
Q1 2019 May 14, 2019	SELL	$7.14 - $9.85 $36,414 - $50,235	-5,100 Reduced 10.9%	41,710 $377,000
Q4 2018 Feb 14, 2019	BUY	$7.26 - $13.29 $124,218 - $227,391	17,110 Added 57.61%	46,810 $389,000
Q2 2018 Aug 08, 2018	BUY	$6.95 - $9.18 $206,415 - $272,646	29,700 New	29,700 $237,000

Others Institutions Holding ALDX

# of Institutions

139

Shares Held

38.6M

Call Options Held

620K

Put Options Held

435K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $125M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Aldeyra Therapeutics, Inc. Transaction History